Success Story: A Statistics Expert from Taiwan Earns NIW Approval without RFE

 

On May 20th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Senior Scientist - Biostatistics in the Field of Statistics (Approval Notice).

 


 

General Field: Statistics

 

Position at the Time of Case Filing: Senior Scientist - Biostatistics

 

Country of Origin: Taiwan

 

State of Residence at the Time of Filing: New Jersey

 

Approval Notice Date: May 20th, 2026

 

Processing Time: 14 months, 6 days

 


 

Case Summary:

 

This approval belongs to a senior biostatistics scientist from Taiwan, whose research sits at the intersection of advanced statistical modeling, drug development, and public health innovation. Holding a Ph.D. in statistics, the client has built a focused research program centered on one of the most pressing challenges in modern medicine: making statistical models more interpretable, flexible, and actionable for clinical decision-making. At the time of filing, the client was actively employed at a leading pharmaceutical company in New Jersey, channeling this expertise directly into real-world drug development pipelines.

 

A Research Record That Speaks for Itself

 

The client's publication record included 3 peer-reviewed journal articles and 1 peer-reviewed conference paper. With 52 citations to date, the research had already demonstrated meaningful reach across multiple disciplines.

 

The petition was supported by two recommendation letters. One expert has stated that:

 

"Given the breakthroughs his research has fostered in these areas, alongside the domain of statistics more generally, [Client]'s work must proceed to benefit both the field and the United States as well."

 

Demonstrating National Importance

 

In preparing the petition, North America Immigration Law Group (Chen Immigration Law Associates) emphasized the national significance of this work by connecting it to well-documented priorities in U.S. healthcare and pharmaceutical competitiveness. The petition demonstrated that the client's research directly addresses critical national needs, reducing drug development costs, improving clinical decision-making, and advancing public health outcomes. The proposed endeavor was also tied to federal policy priorities, demonstrating alignment with areas recognized nationally as essential to U.S. scientific leadership and long-term technological competitiveness.

 

A Positive Outcome

 

This I-140 NIW petition was approved in over 14 months, without an RFE. The result reflects how a well-constructed petition can effectively translate a focused, technically sophisticated research record into a compelling national interest argument, even in a highly specialized field. When rigorous statistical expertise, peer-validated impact, and clearly articulated national relevance come together, the case speaks for itself. We are proud that NAILG had the opportunity to support this researcher on their journey.